Blog

Serial entrepreneur Nessan Bermingham on what’s next for gene editing

nessan-bermingham-triplet-therapeutics900xx1200-800-0-150

While CRISPR has come of age in one sense, gene-editing is still a nascent science, with broad potential as well as challenges. Nessan Bermingham spoke with the Business Journal about the future of the field.

Read More